Beedimani RS, Kalmath B. Canagliflozin: a novel ‘glucuretic’ approach for the treatment of type 2 diabetes mellitus. Int J Basic Clin Pharmacol [Internet]. 2017 Jan. 24 [cited 2025 Sep. 29];3(3):578-80. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1032